Key facts
- Anatomy’s last known valuation is $70.0M (Dec 2024).
- It has raised $26.6M; the latest was Early Stage VC ($19.0M) in Dec 2024.
- Notable investors include Lightspeed Venture Partners, Peterson Partners, Optum Ventures, Canapi Ventures, Cambrian Fintech — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Anatomy
- ·The full record, as it builds
Funding rounds
No funding rounds for Anatomy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Anatomy
Developer of a Financial automation platform intended to operate financial workflow for healthcare. The company's platform offers an AI-powered financial automation system for medical, dental, digital health, and healthcare billing companies by linking bank, claims, and accounting data to provide real-time financial insights and automated reconciliation, enabling healthcare providers to focus on quality patient care.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2022
- Employees
- 31
- Website
- anatomy.com/
- Ownership
- Privately Held (backing)
Anatomy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Anatomy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Anatomy in its N-PORT filings yet. We sweep new filings monthly.